Company Description
AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States, Canada, and the United Kingdom.
The company offers AirSculpt, a body contouring treatment that removes fat and tightens skin while sculpting targeted areas of the body in a minimally invasive procedure.
It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool.
In addition, it provides fat removal procedures across treatment areas, such as the stomach, back, and buttocks; and fat transfer procedures that transfers the patient’s own fat cells to enhance the buttocks, breasts, hips, aging hands, or other areas.
Further, the company’s body contouring procedures include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure.
Additionally, it operates various centers. AirSculpt Technologies, Inc. was founded in 2012 and is headquartered in Miami Beach, Florida.
Country | United States |
Founded | 2012 |
IPO Date | Oct 29, 2021 |
Industry | Medical Care Facilities |
Sector | Healthcare |
Employees | 422 |
CEO | Yogesh Jashnani |
Contact Details
Address: 1111 Lincoln Road, Suite 802 Miami Beach, Florida 33139 United States | |
Phone | 786 709 9690 |
Website | airsculpt.com |
Stock Details
Ticker Symbol | AIRS |
Exchange | NASDAQ |
Stock Type | Common Stock |
Fiscal Year | January - December |
Reporting Currency | USD |
IPO Price | $11.00 |
CIK Code | 0001870940 |
CUSIP Number | 009496100 |
ISIN Number | US0094961002 |
Employer ID | 87-1471855 |
SIC Code | 8011 |
Key Executives
Name | Position |
---|---|
Yogesh Jashnani | Chief Executive Officer and Director |
Dr. Aaron J. Rollins M.D. | Founder and Executive Chairman |
Philip Bodie | Chief Accounting Officer |
Stephanie Evans Greene | Chief Marketing Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Mar 28, 2025 | ARS | Filing |
Mar 28, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
Mar 28, 2025 | DEF 14A | Other definitive proxy statements |
Mar 24, 2025 | EFFECT | Notice of Effectiveness |
Mar 14, 2025 | S-3 | Registration statement under Securities Act of 1933 |
Mar 14, 2025 | 10-K | Annual Report |
Mar 14, 2025 | 8-K | Current Report |
Feb 7, 2025 | SCHEDULE 13G/A | Filing |
Jan 13, 2025 | 8-K | Current Report |
Dec 26, 2024 | 8-K | Current Report |